Clinical trials
Pneumothorax trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 26 |
| Recruiting | 10 |
| Not yet recruiting | 7 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ajou University School of Medicine | 2 |
| Centre Hospitalier Universitaire de Nice | 2 |
| Isala | 2 |
| National Taiwan University Hospital | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| AHEPA University Hospital | 1 |
| Ain Shams University | 1 |
| Al-Quds University | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumothorax | 85 |
| Pleural Effusion | 16 |
| Pulmonary Atelectasis | 8 |
| Hemothorax | 5 |
| Hemorrhage | 4 |
| Pneumonia | 4 |
| Pulmonary Edema | 4 |
| Respiratory Insufficiency | 4 |
| Lung Neoplasms | 3 |
| Pleural Diseases | 3 |
Trials
Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.